Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunosuppressants
Biotech
FDA puts Tenaya heart disease gene therapy trial on hold
The FDA has put a hold on the study while the biotech works to standardize activities related to the immunosuppression regimen across trial sites.
Nick Paul Taylor
Nov 10, 2025 5:16am
Taysha mulls tweaks to gene therapy trial after subject dies
Jan 27, 2022 8:55am
Novartis scraps transplant trial after control beats study drug
Sep 3, 2021 7:17am
Gilead pens buyout option deal for Pionyr
Jun 23, 2020 9:05am
Takeda's CMV med outshines Roche's Valcyte in phase 2
Sep 24, 2019 10:27am
Zealand CSO steps up as chief of French biotech
Sep 6, 2019 8:20am
